Ossur Hf : Transactions in relation to share buyback program
August 19, 2019 at 12:17 pm EDT
Share
Announcement no. 48/2019
19 August 2019
Transactions in relation to share buyback program
On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019.
The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 31 December 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The total consideration for shares purchased under the program shall not exceed USD 10 million.
The following transactions have been made under the program in week 14, the period 12 August 2019 - 16 August 2019:
Transactions
Date
No. of shares
Avg. purchase
price in DKK
Transaction
value in DKK
12 August 2019
9,032
45.53
411,185
13 August 2019
19,550
46.21
903,493
14 August 2019
20,000
45.99
919,832
15 August 2019
25,000
44.34
1,108,575
16 August 2019
20,150
45.23
911,376
Total
93,732
45.39
4,254,461
Össur has acquired 1,455,998 shares under the program at the average price of DKK 41.16. Following the above transactions Össur's holding of own shares is 2,342,266 corresponding to 0.55% of the Company's total share capital.
The share buyback program on Nasdaq Copenhagen is carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ('MAR'), and the Commission delegated regulation No. 2016/1052.
Further information
David Hreidarsson, Investor Relations, [email protected], +354 515 1380
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors
About Össur
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of Prosthetics and Bracing & Supports. A recognized 'Technology Pioneer,' Össur invests significantly in research and product development-its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com
Share buy back transactions 12.08 - 16.08.2019
Attachments
Original document
Permalink
Disclaimer
Össur hf. published this content on 19 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 August 2019 16:16:01 UTC
Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.
EMBLA MEDICAL HF. 
